Revenue Growth
Total revenue of $31.3 million in Q1 2026, up 13% from $27.6 million in Q1 2025.
Recurring Revenue Expansion
Recurring technology-enabled business solution revenue of $23.0 million in Q1 2026, an increase of approximately $5.3 million year-over-year.
Profitability Streak Maintained
GAAP net income of $922,000 in Q1 2026, marking the company's eighth consecutive quarter of positive GAAP net income.
Stable Adjusted Operating Performance
Adjusted EBITDA of $5.4 million (17% of revenue) and adjusted net income of $2.2 million ($0.05 per share) in Q1 2026, essentially in line with prior year comparable adjusted metrics.
Capital Structure Simplification
Closed a new $50 million credit facility ($40M term loan, $10M revolving line) and put an ATM equity facility in place; Board elected to redeem 100% of Series B preferred stock (scheduled May 15) with approximately $41.6 million prefunded—removes preferred overhang with no common shareholder dilution from the redemption itself.
Medsphere Acquisition Integration and Market Expansion
Integration of 2025 acquisitions progressing: entered the inpatient hospital market and added Wellsoft (ED), CareView (inpatient EHR), ChartLogic, Marketware and hospital supply chain/managed IT capabilities—broadening the addressable market and enabling cross-sell opportunities.
Commercial AI Traction
StratusAI Desk Agent reached full commercial release and, across early adopters, is handling approximately 75% of inbound calls automatically; AI Center of Excellence operational and driving product development and internal efficiency.
Reaffirmed 2026 Guidance with Meaningful EPS Upside
Reaffirmed full-year guidance: revenue $128M–$132M; adjusted EBITDA $29M–$31M; GAAP EPS $0.20–$0.23, which would represent more than a 100% increase versus 2025 EPS of $0.10.